High Myopia

Optical and pharmaceutical strategies for myopia control

What is the risk for a child who presents in your practice with myopia - of developing high myopia? What factors do you need to take into consideration and what is the evidence for the different strategies available to manage their progression?

July 21, 2020
Reading time: 4 mins

The Myopia Meeting in San Francisco

Even at age 25 or older, at least 1 in 6 myopes will still progress at least 0.50D over 5 years.

December 20, 2019
Reading time: 3 mins

Understanding the Characteristics of People at Greater Risk

Most infants are hyperopic, and while emmetropization reduces the refractive error, children typically converge to a low level of hyperopia by teen years.

April 12, 2019
Reading time: 2 mins

Latest Post

BHVI partners with VISIONacademy to provide advanced education in optometry and ophthalmology in Spanish

May 26, 2023

Search

About BHVI

Brien Holden Vision Institute (BHVI) is not-for-profit research & development organisation working in the ophthalmic space. It is a company limited by guarantee, incorporated in Australia. It is regulated by the Australian Charities and Not-for-profits Commission (ACNC).

The Charity Programs (ACNC)

Ophthalmic R&D in myopia, presbyopia, astigmatism (Diseases & Conditions).
Optometry Education & Knowledge (Higher Education).
Clinical and metrology services to support R & D technology development (Diseases & Conditions).

The assets and income of BHVI are applied solely towards the promotion and furtherance of the objects of the Company as set out in its constitution.

High Myopia

High Myopia

Optical and pharmaceutical strategies for myopia control

The Myopia Meeting in San Francisco

Understanding the Characteristics of People at Greater Risk

Subscribe

Latest Post

BHVI partners with VISIONacademy to provide advanced education in optometry and ophthalmology in Spanish

Categories

Search

About BHVI

The Charity Programs (ACNC)

Explore